Review articleNF-κB in acute pancreatitis: Mechanisms and therapeutic potential
Introduction
Acute pancreatitis (AP) is an acute inflammation of pancreas that begins with intrapancreatic/acinar activation of trypsinogen to trypsin and culminates in a spectrum of varying degrees of severity including multiple organ failure and death. The incidence of AP is increasing globally and mortality rate could reach as high as 43% among patients with multiple organ failure along with infected pancreatic necrosis [1]. Unfortunately, despite several years of experimental and clinical research the precise pathophysiology of AP, particularly in the clinical context, still remains unclear. This has possibly precluded development of definitive treatment modalities for this potentially life-threatening illness. Irrespective of the etiology, AP mounts an early systemic inflammatory response syndrome (SIRS), the magnitude of which determines the minimal to life-threatening early multiorgan organ dysfunction (MODS) and mortality. Later in the clinical course (second week onwards), development of infected necrosis in a subgroup of patients mounts a second wave of SIRS and MODS (sepsis-related) that is responsible for the second wave of (late) mortality [2].
Experimental and clinical studies over the past decade has reported the profiles of intrapancreatic and circulating cytokines, chemokines, adhesion molecules, and transcription factors, including nuclear factor kappa B (NF-κB) [3], [4]. NF-κB is increasingly gaining importance over the past several years in human inflammation, immune regulation and cancer biology [5]. Studies from last two decades have incriminated NF-κB activation as an early and central event in the progression of inflammation in AP. In clinical practise, researchers have already started evaluating NF-κB as a therapeutic target in the context of cancer and other inflammatory diseases, which could also have profound implication in AP.
The objective of this manuscript is to review the recent literature on the role of NF-κB in the progression of AP and its potential as a therapeutic target in this illness.
Section snippets
Search methods and results
We searched pubmed/medline databases for relevant literature using Boolean logic with the search words acute pancreatitis, NF-κB and nuclear factor kappa B. We did not set any filter during the search so that all studies including experimental, mechanistic, preclinical, and clinical gets included, thus allowing us to achieve the maximum possible volume of relevant data. Three of the authors (AJ, RJ, and RR) evaluated the retrieved abstracts with relevance to the objectives of the review. Full
Overview of NF-κB biology
Often referred to as a ‘double edged sword’, NF-κB is a ubiquitous, pleiotropic, latent cytoplasmic transcription factor. It was discovered by Sen and Baltimore in 1986 as a factor in the nucleus of B cells that binds to enhancer of the kappa light chain of the immunoglobulin molecule [6]. Since then, a substantial volume of data on the biology of NF-κB has appeared in the literature. NF-κB is primarily constituted by a family of five Rel-domain containing proteins namely p65 (RelA), RelB,
Initial mechanisms of intra acinar NF-κB activation after onset of AP
The speculation that NF-κB activation is a key inflammatory event in AP arose from observations by Altavilla et al. in a constitutive model with specific pancreatic NF-κB p50 precursor protein deletion that resulted in a reduced severity of the disease [19]. Although the precise mechanisms responsible for intraacinar NF-κB activation have not been completely elucidated, pathologic calcium signalling, activation of protein kinase C isoforms, and generation of reactive oxygen species have been
NF-κB mediated cytokine release in acute pancreatitis
NF-κB activation during AP is capable of producing numerous types of cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-2, IL-6 and IL-18, various chemokines such as IL-8, macrophage inflammatory protein (MIP)-1, and monocyte chemoattractant protein (MCP)-1, platelet activating factor and adhesion molecules [47], [48], [49]. Several experimental animal models of AP have clearly demonstrated that the acinar cells produce cytokines via activation of NF-κB. Rodent models fed
Activation of NF-κB by released cytokines and other mediators
As discussed earlier, cytokines produced by acinar cells have an emerging role in driving the pancreatic inflammation to systemic inflammation, which possibly activate NF-κB primarily through proinflammatory mediators, specifically TNF-α and IL-1β, which are released from the acinar cells. These signalling cytokines further activates cells with inflammatory property such as lymphocytes, neutrophils, macrophages, and acinar cells.
Therapeutic implications
Despite extensive experimental and clinical research, there still does not exist scientifically proven (based on high quality randomized controlled studies) definitive curative therapy for AP. Several preclinical/experimental studies using a wide array of naturally occurring and synthetic compounds have been conducted so far; and the results demonstrated beneficial effects on murine AP. Several ameliorative mechanisms have also been elucidated in these studies in vivo, in vitro, and in cell
Role of NF-κB inhibition: rationale and implications
Even though several agents have been used for amelioration of AP in an experimental (Table 1) or clinical setting (Table 2), majority of them are unlikely to act via direct NF-κB inhibition. Most of the experimental studies were not specifically targeted against NF-κB and treatment was initiated before induction of injury. Therefore it is not clear whether the beneficial effect followed NF-κB inhibition or it occurred as a part of general reduction in inflammation. However, it would be prudent
Disclosures
- 1.
None of the authors have any conflict of interest to disclose.
- 2.
This manuscript has been supported by Wellcome DBT Fellowship no. IA/I/11/2500257
Author contributions
- •
Aparna: Literature search, data compilation and manuscript drafting.
- •
Ramaiah Jangala and B Ratnakar Reddy: Literature search and manuscript drafting.
- •
Sasikala Mitnala and D. Nageshwar Reddy: Manuscript review and critical inputs.
- •
Rupjyoti Talukdar: Concept, design, critical analysis, revising and finalizing the manuscript.
References (86)
- et al.
Organ failure and infection of pancreatic necrosis as determinants of mortality in patients with acute pancreatitis
Gastroenterology
(2010) - et al.
Multiple nuclear factors interact with the immunoglobulin enhancer sequences
Cell
(1986) RelB forms transcriptionally inactive complexes with RelA/p65
J Biol Chem
(2003)- et al.
Signaling molecules of the NF-kappa B pathway shuttle constitutively between cytoplasm and nucleus
J Biol Chem
(2002) - et al.
Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze the ubiquitination of I kappa B alpha
Mol Cell
(1999) - et al.
Shared principles in NF-kappa B signaling
Cell
(2008) - et al.
Attenuated caerulein-induced pancreatitis in nuclear factor-kappaB-deficient mice
Lab Invest
(2003) - et al.
NF-kappaB/Rel activation in cerulein pancreatitis
Gastroenterology
(1999) - et al.
Ca2+ signaling and pancreatitis: effects of alcohol, bile and coffee
Trends Pharmacol Sci
(2006) - et al.
Fatty acids, alcohol and fatty acid ethyl esters: toxic Ca2+ signal generation and pancreatitis
Cell Calcium
(2009)
Ca2+ signaling and Ca2+activated ion channels in exocrine acinar cells
Cell Calcium
Bile acids induce Ca2+release from both the endoplasmic reticulum and acidic intracellular calcium stores through activation of inositol triphosphate receptors and ryanodine receptors
J Biol Chem
The sevenfold way of PKC regulation
Cell Signal
Effects of cholecystokinin (CCK) and other secretagogues on isoforms of protein kinase C (PKC) in pancreatic acini
Biochim Biophys Acta
Cellular distribution of isoforms of protein kinase C (PKC) in pancreatic acini
Biochim Biophys Acta
Reactive oxygen species induced by bile acid induce apoptosis and protect against necrosis in pancreatic acinar cells
Gastroenterology
Ethanol diet increases the sensitivity of rats to pancreatitis induced by cholecystokinin octapeptide
Gastroenterology
Ethanol metabolism and transcription factor activation in pancreatic acinar cells in rats
Gastroenterology
NF-kappaB activation is detrimental in arginine-induced acute pancreatitis
Free Radic Biol Med
Tumor necrosis factor-α mediates pancreatitis responses in acinar cells via protein kinase C and proline-rich tyrosinekinase 2
Gastroenterology
TNF but not IL-1 decreases pancreatic acinar cell survival without affecting exocrine function: a study in the perfused human pancreas
J Surg Res
The biology of the receptor for advanced glycation end products and its ligands
Biochim Biophys Acta
Pioglitazone, a PPAR gamma ligand, suppresses NF-kappaB activation through inhibition of IkappaB kinase activation in caerulein-treated AR42J cells
Biomed Pharmacother
Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus
Gut
Nuclear factor kappa B expression in peripheral blood mononuclear cells of patients with acute pancreatitis
Pancreas
Different profiles of cytokine expression during mild and severe acute pancreatitis
World J Gastroenterol
The complexity of NF-κB signaling in inflammation and cancer
Mol Cancer
NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions
Clin Microbiol Rev
NF-κB, the first quarter-century: remarkable progress and outstanding questions
Genes Dev
Integrating cell-signaling pathways with NF-kappa B and IKK function
Nat Rev Mol Cell Biol
Non-canonical NF-κB signaling pathway
Cell Res
Charting the NF-κB pathway interactome map
PLoS One
The N-terminal domain of I kappaB alpha masks the nuclear localization signal(s) of p50 and c-Rel homodimers
Mol Cell Biol
Deubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappa B signaling
Nature
CYLD is a deubiquitinating enzyme that negatively regulates NF-kappa B activation by TNFR family members
Nature
Molecular mechanisms of pancreatic injury
Curr Opin Gastroenterol
New insights into the pathogenesis of pancreatitis
Curr Opin Gastroenterol
Caerulein-induced NF-kB/Rel activation requires both Ca2+ and protein kinase C as messengers
Am J Physiol
Pancreatic acinar cell nuclear factor kB activation because of bile acid exposure is dependent on calcineurin
J Biol Chem
Pharmacological and genetic inhibition of calcineurin protects against carbachol-induced pathological zymogen activation and acinar cell injury
Am J Physiol Gastrointest Liver Physiol
Calcineurin. Form and function
Physiol Rev
NFATc3 regulates trypsinogen activation, neutrophil recruitment, and tissue damage in acute pancreatitis in mice
Gastroenterology
Role of PKC-δ on substance P-induced chemokine synthesis in pancreatic acinar cells
Am J Physiol Cell Physiol
Cited by (114)
Pyrazole derivative Z10 ameliorates acute pancreatitis by inhibiting the ERK/Ddt pathway
2024, Biochimica et Biophysica Acta - Molecular Basis of DiseaseBiochanin A ameliorates caerulein-induced acute pancreatitis and associated intestinal injury in mice by inhibiting TLR4 signaling
2023, Journal of Nutritional BiochemistryCitation Excerpt :Mechanistically, BCA-exerted AP attenuation and intestinal barrier integrity are associated with inhibition of TLR4-MAPK/NF-κB signaling and NLRP3 inflammasome activation (Fig. 7). During AP, injured acinar cells release cytokines such as TNF-α, IL-1β, IL-6 and chemokines including MCP-1 that recruit and mediate infiltration of immune cells into the site of injury [5,30], which is associated with propagated inflammation of AP [31]. Currently, inhibition of cytokines and chemokines or inactivation of their receptors have been proposed to prevent pancreatic and distant organ injury in clinical or animal studies [32–34].
Tropolone derivative hinokitiol ameliorates cerulein-induced acute pancreatitis in mice
2022, International Immunopharmacology